CD28 and cancer: In addition, a significant positive correlation observed between AIF-1 and several immune regulators, including LAIR1, CD244, LAG3, ICOS, CD48, CD28, HAVCR, CD80, PDCD1, CD27, VSIR, CD86, and TNFRSF9 in most cancers.